Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WR 279,396 for Cutaneous Leishmaniasis in Tunisia
NCT01494350Phase 2Terminated
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Dec 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WR 279,396 in cutaneous leishmaniasis (CL), sponsored by U.S. Army Medical Research and Development Command. Started Dec 2011; status: terminated.
02
Drugs
WR 279,396
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT01494350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494350.